Market Research Logo

Croatia Pharmaceuticals and Healthcare Report Q2 2016

Croatia Pharmaceuticals and Healthcare Report Q2 2016

BMI View: Continued political instability coupled with a bleak economic outlook will continue to repressthe pharmaceutical and healthcare sectors in Croatia. Necessary austerity measures will impose furtherbarriers towards growth and reduce the use of high-value patented drugs, highlighting minimal revenueearning opportunities for multinational pharmaceutical firms.

Headline Expenditure Projections

Pharmaceuticals: HRK6.73bn (USD961mn) in 2015 to HRK6.76bn (USD931mn) in 2016; 0.5% inlocal currency and -3.2% in US dollar terms. Forecast revised upwards compared with Q116.

Healthcare: HRK21.99bn (USD3.14bn) in 2015 to HRK21.66bn (USD2.99bn) in 2016; -1.5% in localcurrency and -5.1% in US dollar terms. Forecast revised slightly upwards compared with Q116.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Croatia 2014
2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Croatia 2012
2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Croatia 2012
2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Croatia 2012
2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Croatia 2012
2020)
Prescription Drug Market
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Croatia 2012
2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Croatia 2012
2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Croatia 2012
2020)
OTC Medicine Market Forecast
Table: Over
TheCounter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Croatia 20122020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Croatia 2014
2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Croatia 2014
2020)
Industry Risk Reward Index
Central And Eastern Europe Risk/Reward Index
Croatia Risk/Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Issues
Pricing Regime
Table: New Profit Margins For Wholesalers
Reimbursement Regime
Risk Sharing Schemes
Pharmaceutical CostEffectiveness Measures
OTC Regulations
Generic Regulations
Biosimilars
Market Overview
Healthcare Sector
Table: Healthcare Resources (Croatia 2010
2015)
Table: Healthcare Personnel (Croatia 2010
2015)
Table: Healthcare Activity (Croatia 2010
2015)
Table: Reimbursed Drug Expenditure By HZZO (HRKbn)
Equivalent To Final Consumer Prices
Research & Development
Clinical Trials
Epidemiology
Table: Cancer Incidence Rates, 2010
2035
Competitive Landscape
ResearchBased Industry
Table: Multinational Market Activity
Generic Drugmakers
Pharmaceutical Distribution
Pharmaceutical Retail
Company Profile
Belupo
Jadran Galenski Laboratorij
PLIVA
Demographic Forecast
Table: Population Headline Indicators (Croatia 1990
2025)
Table: Key Population Ratios (Croatia 1990
2025)
Table: Urban/Rural Population & Life Expectancy (Croatia 1990
2025)
Table: Population By Age Group (Croatia 1990
2025)
Table: Population By Age Group % (Croatia 1990
2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report